two are due to C1 inhibitor (C1-INH) deficiency (C1-INH-HAE types I and II) and one is characterized by normal C1-INH (nC1-INH-HAE). The management of pregnancy in patients with HAE is often a clinical challenge owing to potential worsening of the disease in relation to the physiological increase in estrogens and the limited treatment options. This review addresses the potential influence of pregnancy on the clinical severity of hereditary angioedema and the management of this disease during pregnancy with currently available treatments.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164109 | PMC |
| http://dx.doi.org/10.2147/IJWH.S46460 | DOI Listing |
Publication Analysis
Top Keywords
hereditary angioedema
8
management hereditary
4
angioedema pregnant
4
pregnant women
4
women review
4
review inhibitor
4
inhibitor c1-inh
4
c1-inh deficiency
4
deficiency c1-inh-hae
4
c1-inh-hae types
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!